Cytotoxicity is an important virulence determinant in the pathogenesis of Vibrio vulnificus, and two cytotoxins, RTX (encoded by rtxA1) and cytolysin/hemolysin (encoded by vvhA), have been identified in this organism. We showed that the quorum-sensing regulator LuxO controlled the cytotoxicity of this organism: a ⌬luxO mutant exhibited low cytotoxicity, whereas a constitutively activated luxO mutant, luxO(D47E), remained highly cytotoxic. The cytotoxicity of the ⌬luxO mutant was restored when smcR, a Vibrio harveyi luxR homologue repressed by luxO, was further deleted. SmcR then was shown to repress the expression of both rtxA1 and vvhA. A DNA library of V. vulnificus was screened in Escherichia coli for clones that upregulated vvhA in the presence of SmcR, and hlyU, which has been shown to positively regulate rtxA1 and vvhA, was identified. We demonstrated that SmcR repressed the expression of hlyU and bound to a region upstream of hlyU in V. vulnificus. The deletion of hlyU resulted in the loss of cytotoxicity and reduced cytolysin/hemolysin production in the ⌬smcR mutant. The ⌬smcR ⌬hlyU mutant regained cytotoxicity and cytolysin/hemolysin activity when hns, which has been shown to repress the transcription of rtxA1 and interfere with hlyU, was further removed. Collectively, our data suggest that SmcR mediates the regulation of cytotoxicity by quorum-sensing signaling in V. vulnificus by repressing hlyU, an activator of rtxA1 and vvhA.
Vibrio vulnificus, a Gram-negative marine bacterium, is an opportunistic pathogen causing septicemia and wound infection in humans; it has a high mortality rate, particularly in those who suffer from chronic liver diseases or are immunocompromised. This organism produces two major cytotoxins, cytolysin/hemolysin (encoded by vvhA) and RTX (repeats in toxin; encoded by rtxA1), that are implicated in its virulence (19, 29) . The cytolysin/hemolysin, which is an extracellular product, is lethal for mice at submicrogram levels. It lyses erythrocytes, increases vascular permeability (resulting in extensive extracellular edema in guinea pig skin), damages capillary endothelial cells, and causes mild inflammatory cell infiltration (7, 8) . The RTX toxin, which forms pores on cell membranes only after the contact of the bacterium with the host cell (12, 13) , is required for V. vulnificus virulence in mice by promoting bacterial colonization at the infection site and subsequent invasion into the bloodstream (12, 15) .
Several regulators of vvhA and rtxA1 have been identified (1, 19) . HlyU, which was identified by in vivo-induced antigen technology and is essential for V. vulnificus virulence in mice (11, 19) , is required for the expression of vvhA and rtxA1 and binds directly to a region upstream of the operon where rtxA1 is located (19, 20) .
Quorum-sensing (QS) signaling, which is widely used by bacteria to communicate with each other, regulates the virulence genes in a variety of microorganisms, including Vibrio species (23, 30) . In Vibrio cholerae, the signals transduced from at least three QS sensory circuits integrate into LuxO, a repressor of hapR (a luxR homologue) that negatively regulate the virulence regulon (30) . The repression of hapR by LuxO is mediated by a set of QS-regulatory small RNAs, qrr1-4. In detail, the activated LuxO, together with RpoN, turns on the expression of qrr1-4, and these small RNAs in turn destabilize hapR mRNA in the presence of the qrr-binding protein Hfq (18) .
The homologues of most genes of QS signaling in V. cholerae, including luxS (coding for the synthesis of autoinducer AI-2), luxO, qrr1-4, and hapR, are found in the whole-genome sequences of V. vulnificus strains YJ016 (2) and CMCP6. Kim et al. have reported that, in the absence of AI-2 (caused by a deletion in luxS), the production of protease was delayed and cytolysin/hemolysin production was increased. Further, these changes were complemented by AI-2 contained in the logphase spent medium of the wild-type V. vulnificus (10) . These findings suggest that the expression of both the protease and cytolysin/hemolysin is regulated by quorum-sensing signaling. However, whether QS is involved in the regulation of cytotoxicity mediated by cytolysin/hemolysin and RTX toxin remains unclear. Therefore, we designed experiments to determine if the cytotoxicity of V. vulnificus is regulated by QS and further explore the mechanism of regulation.
MATERIALS AND METHODS
Bacterial strains, plasmids, and primers. The bacterial strains and plasmids used are listed in Table 1 , and the primers used are listed in Table S1 in the supplemental material. The nucleotide sequences of primers were derived from the whole-genome sequence of V. vulnificus strain YJ016 (NCBI accession no. NC 005139-40). The bacteria were grown at 37°C with shaking at 240 rpm in Luria-Bertani (LB) medium, to which ampicillin (100 g/ml), polymyxin B (50 U/ml), or kanamycin (50 g/ml) was added as appropriate. Throughout this study, a 4-h culture at 37°C, starting from a 100-fold dilution of an overnight culture, was used to infect the cultured cells. DNA preparation and manipulation. The plasmid and genomic DNAs were purified by a Wizard plasmid/genomic DNA purification kit (Promega, Madison, WI). Standard techniques were used to construct the recombinant plasmids (25) . DNA restriction endonucleases and T4 DNA ligase were from New England BioLabs. PCR was performed as described previously (26) with a thermocycler (Mastercycler gradient; Eppendorf AG, Hamburg, Germany).
Isolation of V. vulnificus mutants and their complemented strains. V. vulnificus mutants with deletions in luxO, rtxA1, vvhA, hlyU, and hns, as well as the luxO D47E mutant, which contains an Asp-to-Glu mutation at the 47th residue that results in a constitutively active LuxO in V. harveyi (6) , were isolated by in vivo allelic exchange (26) . Briefly, for the isolation of deletion mutants, derivatives of suicide plasmid pCVD442, containing various DNA fragments with the desired deletions, first were constructed by the ligation of pCVD442 linearized by an appropriate restriction enzyme with the PCR-amplified upstream and downstream DNA fragments flanking the deletion. The corresponding primer pairs used to amplify the upstream (U) and downstream (D) DNA fragments were UVV1195F-UVV1195R and DVV1195F-DVV1196R for luxO, UVVA0965F1-UVVA0965R and DVVA0965F-DVVA0965R for vvhA, UVV0683F-UVV0683R and DVV0683F-DVV0683R for hlyU, and UVV1346F-UVV1346R and DVV1346F-DVV1346R for hns (see Table S1 in the supplemental material). The resultant plasmids were p⌬luxO, p⌬vvhA, p⌬hlyU, and p⌬hns (1,311, 1,032, 210, and 300 bp, respectively). In-frame deletions then were used to generate the specific gene knockout mutants. The ⌬rtxA1 mutants were isolated as described previously (21) .
The luxO(D47E) mutant was isolated similarly, except that the mutation was introduced into pOU1, a pUC19 derivative containing the luxO gene amplified with primers vlo7 and vlo10, by a QuikChange site-directed mutagenesis kit (Stratagene, CA) and primers D47EF and D47ER (see Table S1 ). The pCVD442 derivative carrying the luxO(D47E) mutation (pluxO D47E ) was transferred to the ⌬luxO mutant instead of the wild-type strain to facilitate the screening of mutants by PCR.
For the complementation of the ⌬smcR mutant, a 2.1-kb NheI-NheI DNA fragment that contained the entire smcR gene was excised from pVR11 (pBR322 with smcR inserted) and was inserted into the XbaI site of pCVD442 to generate psmcR. This plasmid then was transferred to the ⌬smcR mutants by conjugation, and the transconjugants with the whole plasmid integrated adjacent to the deletion in smcR by homologous recombination were selected. For the complementation of the ⌬hlyU mutants, a 776-bp BglII-BamHI DNA fragment with the entire hlyU gene was cloned from pVR11.2-L24 (pBR322 derivative containing hlyU) into the BamHI site of pJRD215, a broad-host-range plasmid, and the recombinant plasmid then was transferred to the ⌬hlyU mutants by conjugation. For the complementation of the ⌬hns mutants, a 2,041-bp, hns-containing DNA fragment amplified by PCR with primers UVV1346F and DVV1346R was cloned into the SacI site of pCVD442. The resultant plasmid subsequently was transferred to the ⌬hns mutants by conjugation, and the transconjugants with the whole plasmid integrated adjacent to the deletion in hns by homologous recombination were selected.
Cytotoxicity assay. Monolayers of HEp-2 cells, about 1.5 ϫ 10 4 cells per well in a 96-well microplate, were infected with phosphate-buffered saline (PBS)-washed bacteria harvested from a 4-h culture at a multiplicity of infection (MOI) of 10 for 4 h. The infected monolayer then was assayed for cell lysis with a CytoTox 96 nonradioactive cytotoxicity kit (Promega) that measures the activity of lactate dehydrogenase (LDH) released from lysed cells. The cytotoxicity is expressed as 100 ϫ [(LDH activity of infected monolayer Ϫ LDH activity of monolayer treated with medium)/(the LDH activity of monolayer treated with lysis buffer Ϫ LDH activity of monolayer treated with medium)].
Cytolysin/hemolysin assay. The amount of cytolysin/hemolysin produced in culture supernatant or conditioned medium of infected cells was assayed by the hemolysis of mouse red blood cells (RBCs). The sample was mixed with an equal volume of mouse RBC suspension (0.7 to 0.9% in PBS), and the mixture was incubated at 37°C for 30 min. The unlysed RBCs and cell debris were pelleted by centrifugation, and the optical density at 545 nm (OD 545 ) of the supernatant, which represents the level of hemolysis, was measured. The cytolysin/hemolysin level is expressed as 100 ϫ (OD 545 of RBC suspension treated with sample/ OD 545 of RBC suspension treated with 1% Triton X-100).
RNA isolation and cDNA synthesis. Total RNA was extracted from V. vulnificus cells by TRI reagent (Sigma-Aldrich), and the concentration of RNA was determined with a BioPhotometer (Eppendorf). DNA contaminants were removed by DNase (RQ1 RNase-free DNase; Promega) before RNA precipitation by ethanol. The cDNA of total RNA (2 g per reaction mixture) was synthesized with a high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA).
Real-time PCR. Real-time PCR was performed with Mastercycler ep realplex (Eppendorf). The standard 1ϫ real-time PCR mixture contained 12.5 l 2ϫ Power SYBR green PCR master mix (Applied Biosystems), 50 ng cDNA, and 200 nM (each) forward and reverse primers. The 23S rRNA gene was used as an internal control, and the experiment was performed in triplicate. The reaction consisted of an initial denaturing at 95°C for 10 min, followed by 40 cycles of denaturing at 95°C for 15 s and annealing at 60°C for 60 s. DNA polymerization was conducted in a range of temperatures from 60 to 95°C within 20 min to obtain the melting curve for determining the PCR amplification specificity. The threshold cycle (C T ) value and relative change in expression level were determined by automated threshold analysis with Realplex software, v. 1.5 (Eppendorf).
Construction of the reporter strains and ␤-galactosidase assay. The Escherichia coli DH5␣ reporter strains, which expressed lacZ under the control of various V. vulnificus promoters, were constructed for studying the regulation of these promoters. To construct the PvvhBA-lacZ fusion, a 675-bp DNA fragment that contained the promoter of the vvhBA operon and an NdeI restriction site with a start codon, ATG, was amplified by PCR with primers pvvhF and pvvhR. The PCR product was cloned into pVP84, which contained a promoterless lacZ To assay the activity of the promoter fused with lacZ in a reporter strain, an overnight bacterial culture starting with a single colony picked from a 2-day plate culture was 100-fold diluted in fresh LB medium and incubated at 37°C with shaking. An aliquot of the culture then was collected at intervals, and the ␤-galactosidase activity in the culture supernatant was determined as described previously (22) .
Library construction, screening, and subcloning. The genomic DNA was extracted from V. vulnificus YJ016 and partially digested with Sau3AI, and the DNA fragments ranging from 3 to 6 kb were recovered and ligated to the BamHI-linearized pVR11.2, a pBR322 derivative containing the intact smcR gene. The resultant plasmids were introduced into E. coli strain KV372, which carried pVH84 that contained the PvvhBA-lacZ fusion, by transformation to generate a DNA library for screening the gene(s) that could mediate the regulation of vvhA. The blue colonies, which indicated enhanced vvhBA promoter activity by the gene cloned into pVR11.2 on 5-bromo-4-chloro-3-indolyl-beta-Dgalactopyranoside (X-gal)-containing plates, were selected for further characterization.
Production and purification of SmcR with a His 6 tag at C terminus. The smcR gene with its promoter was amplified by PCR with primers VR22 and VR24, and the PCR product was cloned into pET30b between XbaI and XhoI, a site 5Ј to the His 6 tag, to generate pVR282. To express the SmcR-His 6 protein in V. vulnificus, the smcR-His tag DNA fragment was amplified from pVR282 by PCR with primers VR22 and VRT7 and then cloned into pJRD215 to generate pVR35. To avoid the degradation of SmcR by the extracellular metalloprotease (Vvp) during purification, pVR35 was introduced into a Vvp-deficient V. vulnificus mutant. The ⌬smcR ⌬vvp V. vulnificus mutant was isolated by introducing a deletion in vvp of CP156 (⌬smcR mutant) with pSI026, a suicide plasmid carrying ⌬vvp, as described previously (26) . The resultant strain was grown in LB at 37°C to an OD 600 of 5, and the bacterial cells were pelleted and then lysed by a French press to release SmcR-His 6 recombinant protein. SmcR-His 6 in the soluble fraction was purified by affinity chromatography with HisTrap HP columns (GE Healthcare). The concentration of purified SmcR-His 6 was estimated by a Bio-Rad protein assay kit.
Gel mobility shift assay. The biotin-labeled probes A, B, and C were amplified from the hlyU promoter region by PCR with biotin-labeled primer pairs phlyUF3-phlyURB, phlyUF3B-phlyUR1, and phlyUF4-phlyURB, respectively. Purified SmcR-His 6 was incubated with the probe for 30 min in the presence of 1 g poly(dI-dC) (used as a nonspecific competitor) as suggested by the manufacturer of the Panomics electrophoretic mobility shift assay (EMSA) kit (Redwood City, CA). The mixture then was fractionated by electrophoresis on a native polyacrylamide gel (6%) and transferred to a membrane, and the probe was visualized by chemiluminescence with the Panomics EMSA kit.
Statistical analysis. The cytotoxicity and cytolysin/hemolysin activity in V. vulnificus strains and the levels of ␤-galactosidase from lacZ driven by vvhBA promoter in E. coli DH5␣ containing various pVR11.2 derivatives were compared using one-way analysis of variance (ANOVA) with Tukey's honestly significant difference (HSD) test. The mRNA levels and the effect of SmcR on the expression of hlyU in various V. vulnificus strains were compared using one-way ANOVA with Dunnett's post test and two-way ANOVA with Bonferroni's post test, respectively. All experiments were repeated three times, and the results from a representative experiment were expressed as means Ϯ standard deviations (SD) for each group examined. All tests were performed with GraphPad Prism 4.0, and statistical significance was defined as P Ͻ 0.05.
RESULTS
Cytotoxicity diminished in ⌬luxO mutant is restored when smcR is further deleted. To investigate the involvement of LuxO in the expression of cytotoxicity in V. vulnificus, the cytotoxicity of a ⌬luxO mutant and a constitutively active luxO mutant, luxO(D47E), was assessed. The ⌬luxO mutant exhibited very low cytotoxicity to HEp-2 cells compared to that of the wild-type strain (P Ͻ 0.001), while the luxO(D47E) mutant was as cytotoxic as the wild-type strain after coincubation for 4 h at an MOI of 10 (Fig. 1A) . This indicates that LuxO is associated with the expression of V. vulnificus cytotoxicity.
While the expression of SmcR is negatively regulated by LuxO (24) , to determine the role of SmcR in the regulation of cytotoxicity by LuxO, we further deleted smcR in the ⌬luxO and luxO(D47E) mutants and determined the cytotoxicity of these double mutants. We found that the luxO(D47E) ⌬smcR mutant remained as cytotoxic as the luxO(D47E) mutant, but the cytotoxicity of the ⌬luxO ⌬smcR mutant, compared to that of the ⌬luxO mutant, was greatly enhanced (P Ͻ 0.001) (Fig.  1A) . When the ⌬luxO ⌬smcR mutant was complemented with smcR, the cytotoxicity was reduced to a level comparable to that of the ⌬luxO mutant (Fig. 1A) . These results suggest that the regulation of cytotoxicity by LuxO is mediated by SmcR, which could repress cytotoxicity.
Cytotoxicity downregulated by smcR is attributed to RTX and cytolysin/hemolysin. To determine the contribution of RTX and cytolysin/hemolysin to the cytotoxicity of the ⌬luxO ⌬smcR mutant, vvhA and rtxA1 of this mutant were further deleted, and the cytotoxicity of each resultant mutant was measured. The cytotoxicity of the ⌬luxO ⌬smcR ⌬rtxA1, ⌬luxO ⌬smcR ⌬vvhA, and ⌬luxO ⌬smcR ⌬vvhA ⌬rtxA1 mutants to HEp-2 cells was reduced to about 54 (P Ͻ 0.001), 76 (P Ͻ 0.05), and 8.5% (P Ͻ 0.01), respectively, of that of the ⌬luxO ⌬smcR mutant (Fig. 1A) . The reintroduction of smcR into the ⌬luxO ⌬smcR ⌬rtxA1 or ⌬luxO ⌬smcR ⌬vvhA mutant resulted in reduced cytotoxicity (P Ͻ 0.01 and 0.001, respectively) to a level similar to that of the ⌬luxO ⌬smcR ⌬vvhA ⌬rtxA1 mutant (Fig. 1A) . However, the reintroduction of smcR into the ⌬luxO ⌬smcR ⌬vvhA ⌬rtxA1 mutant did not reduce the cytotoxicity any further (Fig. 1A) . These findings suggest that the cytotoxicity downregulated by SmcR is attributed to both cytolysin/ hemolysin and RTX.
SmcR downregulates cytolysin/hemolysin production. Mouse RBCs were lysed by treatment with the culture supernatant of a wild-type V. vulnificus; however, little hemolysis was detected in the culture supernatant of a cytolysin/hemolysindeficient mutant (5). This indicates that cytolysin/hemolysin is an extracellular product but RTX is not. Since cytolysin/hemolysin contributed to the cytotoxicity detected in the coculture of bacteria and HEp-2 cells, we determined whether cytolysin/ hemolysin was detectable in the conditioned medium by hemolysis assay with mouse RBCs. The wild-type strain exhibited a low level of hemolysis in the conditioned medium, but that of the luxO(D47E), luxO(D47E) ⌬smcR, or ⌬luxO ⌬smcR mutant, in which SmcR was either deficient or downregulated, was higher (P Ͻ 0.001) (Fig. 1B) . The deletion of vvhA, but not rtxA1, in the ⌬luxO ⌬smcR mutant abolished the hemolytic activity in conditioned medium (Fig. 1B) , showing that indeed cytolysin/hemolysin, and only it, was secreted in the conditioned medium. The hemolytic activity in conditioned medium became almost undetectable when the ⌬luxO ⌬smcR and ⌬luxO ⌬smcR ⌬rtxA1 mutants were complemented with smcR (P Ͻ 0.001 compared to each parent strain) (Fig. 1B) , indicating a negative correlation of smcR with the amount of cytolysin/hemolysin secreted.
LuxO and SmcR regulate expression of rtxA1 and vvhA at transcriptional level. To determine if the regulation of cytotoxicity by LuxO and SmcR is through affecting the transcription of vvhA and rtxA1, the mRNA levels of these two genes in the various luxO and smcR mutants after coincubation with HEp-2 cells were estimated by real-time reverse transcription-PCR (RT-PCR). As was expected, compared to that of the wild-type strain, the mRNA level of smcR was 2-fold increased in the ⌬luxO mutant (P Ͻ 0.01), but that in the luxO(D47E) mutant was reduced (P Ͻ 0.01) (Fig. 2A) . Meanwhile, the mRNA levels of both rtxA1 and vvhA in the luxO(D47E) mutant, in which smcR was downregulated, were higher than those in the ⌬luxO mutant (P Ͻ 0.01 and 0.05, respectively), in which smcR was upregulated ( Fig. 2B and C) . Nevertheless, when smcR in the ⌬luxO mutant was further deleted, both rtxA1 and vvhA were upregulated (P Ͻ 0.01) (Fig. 2B and C) .
Taken together, these data indicate that SmcR negatively regulated the transcription of rtxA1 and, more evidently, vvhA, and in the absence of LuxO, SmcR was upregulated to result in the decreased expression of both rtxA1 and vvhA. In addition, the cytotoxicity to HEp-2 cells and hemolytic activity of the various luxO and smcR mutants (Fig. 1A and B) correlated well with the mRNA levels of rtxA1 and vvhA (Fig. 2B and C) .
HlyU mediates the regulation of vvhA by SmcR. To identify the gene(s) that mediates the regulation of vvhA by SmcR, we screened a V. vulnificus DNA library in an E. coli strain, KV372, which contained a transcriptional fusion of the vvhBA promoter and lacZ (PvvhBA-lacZ) as a reporter, for clones showing upregulated PvvhBA-lacZ in the presence of SmcR. Three out of approximately 8,000 clones screened exhibited deep blue colonies on the X-gal plates after prolonged incubation. One of them, whose plasmid was designated pVR11.2-L24, contained three intact open reading frames (ORFs), VV0681, VV0682, and VV0683, while the others contained the lacZ gene. We further constructed four subclones from pVR11.2-L24 (Fig. 3A) and found that only those (pVR11.2-L243 and pVR11.2-L244) containing ORF VV0683, which encodes HlyU, could upregulate PvvhBA-lacZ (P Ͻ 0.001 compared to the vector control, pVR11.2) (Fig. 3B) . When the intact smcR gene in pVR11.2-L244 was replaced by ⌬smcR 3-L244 ), the expression of PvvhBA-lac was further increased (P Ͻ 0.001) (Fig. 3B) . hlyU is involved in regulation of cytotoxicity by QS signaling. HlyU has been shown to activate the expression of both vvhA and rtxA1 (19) . Consistently with this finding, the cytotoxicity and cytolysin/hemolysin levels of the ⌬hlyU mutant were abolished (P Ͻ 0.001 and 0.05, respectively) compared to those of the wild-type strain, and the complementation of the ⌬hlyU mutant with hlyU restored these properties (Fig. 4A and C) .
To test whether hlyU is associated with the regulation of cytotoxicity and cytolysin/hemolysin production by QS signaling in V. vulnificus, this gene in the SmcR-deficient or downregulated mutants was deleted, and the resultant mutants were assayed for these properties. The cytotoxicity of the ⌬smcR, luxO(D47E), and ⌬luxO ⌬smcR mutants was greatly reduced when their hlyU gene was further deleted (P Ͻ 0.001 for all of them) (Fig. 4B) . Meanwhile, the hemolytic activity in the conditioned medium of cells infected by these ⌬hlyU mutants was reduced in all of them (P Ͻ 0.01, 0.05, and 0.01 for the ⌬smcR ⌬hlyU, luxO(D47E) ⌬hlyU, and ⌬luxO ⌬smcR ⌬hlyU mutants, respectively) (Fig. 4D) . The complementation of these mutants with hlyU restored these properties (Fig. 4B and D) .
SmcR downregulates hlyU. To test whether hlyU is regulated by SmcR, the hlyU expression levels in the ⌬luxO, luxO(D47E), and ⌬luxO ⌬smcR mutants after coincubation with HEp-2 cells were estimated by real-time RT-PCR. The transcriptional level of hlyU was increased in luxO(D47E), in which smcR was downregulated, and ⌬luxO ⌬smcR mutants (P Ͻ 0.05) compared to that of the ⌬luxO mutant in which smcR was upregulated (Fig. 2D) .
In another experiment, a DNA fragment containing the intergenic region between VV0682 and hlyU was cloned into pVP84 to generate PhlyU-lacZ as a reporter, and the resultant plasmid, pVU84, was introduced into the smcR ϩ and ⌬smcR isogenic strains. Compared to that of the smcR ϩ strain, the ⌬smcR mutant exhibited higher hlyU promoter activity at 3 and 4 h of growth in LB broth (P Ͻ 0.001 and 0.01, respectively) (Fig. 5A) .
SmcR binds to hlyU promoter region. A gel mobility shift assay then was performed with the purified His 6 -tagged SmcR to determine whether SmcR binds to the promoter of hlyU. A hlyU promoter-containing DNA fragment (probe A in Fig. 5B ) was upshifted in the presence of increasing amounts (from 75 to 300 nM) of SmcR-His 6 (Fig. 5C) . The SmcR-binding site was further mapped to the region between Ϫ62 and Ϫ128 bp (probe B in Fig. 5B ) upstream of hlyU, as the DNA fragment corresponding to this region caused a band shift but the other fragment (probe C in Fig. 5B ), corresponding to a region between ϩ6 and Ϫ61, did not (Fig. 5D) .
H-NS represses cytotoxicity and cytolysin/hemolysin activity. Recently, ORF VV12923 of V. vulnificus strain CMCP6 that encodes an H-NS universal regulator was shown to act as an rtxA1 repressor and compete with HlyU for binding to the rtxA1 promoter region (20) . To test whether H-NS is a repressor of cytotoxicity and cytolysin/hemolysin production, the hns gene (ORF VV1346 in strain YJ016) of the wild-type, ⌬hlyU, and ⌬smcR ⌬hlyU strains was further deleted, and the resultant mutants were characterized. The deletion of hns resulted in increases of both the cytotoxicity (except for the wild-type strain, which already showed full cytotoxicity) and cytolysin/ hemolysin production in all three strains (P Ͻ 0.001) (Fig. 6A  and B) . Moreover, the complementation of these ⌬hns mutants with hns led to a reduction of cytotoxicity (except for the ⌬hns mutant, which was HlyU proficient) and cytolysin/hemolysin production (P Ͻ 0.001).
DISCUSSION
In this study, the requirement of the QS regulator, LuxO, in the expression of V. vulnificus cytotoxicity was confirmed, and the role of SmcR, a regulator repressed by LuxO (24) , in the negative regulation of cytotoxicity was demonstrated (Fig. 1A) . Both RTX and the cytolysin/hemolysin VvhA contributed to the cytotoxicity to HEp-2 cells regulated by QS signaling (Fig.  1A) . Further, the transcriptional levels of both rtxA1 and vvhA in the luxO(D47E) mutant, which exhibited full cytotoxicity, were significantly higher than those of the ⌬luxO mutant, which lost cytotoxicity (Fig. 2B and C) . These results indicate that the induction of cytotoxicity by QS occurs by activating the transcription of these two cytotoxin genes.
The involvement of RTX in V. vulnificus cytotoxicity has been demonstrated, as RTX-deficient mutants exhibit reduced cytotoxicity (15, 19) . Several possible mechanisms, including pore formation on the target cell membrane and inducing the apoptosis of the host cells, have been proposed for the cytotoxicity of RTX (12, 13, 15) . The ⌬luxO mutant was shown to be about 100-fold less virulent than the wild-type strain or luxO(D47E) mutant, and its spread into the bloodstream was much slower in mice infected subcutaneously (our unpublished data). These phenotypes of the ⌬luxO mutant are similar to those of an RTX-deficient mutant (15, 19, 21) , suggesting a close association of LuxO with RTX-mediated cytotoxicity and virulence in mice.
The role of cytolysin/hemolysin in cytotoxicity is equivocal. Although this protein can cause the cytotoxicity of cultured cells (17, 29) , cytolysin/hemolysin-deficient mutants are as cytotoxic as the wild-type strain when they are coincubated with the cells (5, 12, 29) . As has been noticed by Kim et al. previously (12) , the RTX-deficient mutant still caused cell lysis, and cytolysin/hemolysin was detected in the conditioned medium when it was cocultured with the HEp-2 cells at an MOI of 100 for 4 h (data not shown). The cytotoxicity and cytolysin/hemolysin activity of the RTX-deficient mutants became more evident when cytolysin/hemolysin was overexpressed in mutants deficient in SmcR (Fig. 1A and B) . As it has been shown that cytolysin/hemolysin is substantially produced in vivo (17) , the role of this cytotoxin in pathogenesis needs to be reinvestigated.
We then found that hlyU, an activator of both vvhA and rtxA1 (11, 19) , mediated the regulation of vvhA by SmcR in E. coli. In V. vulnificus, the deletion of hlyU in the ⌬smcR mutant resulted in the abolition of cytolysin/hemolysin activity (Fig.  4B ), indicating that HlyU is required for the upregulation of vvhA in the ⌬smcR mutant. We further showed that the promoter activity of hlyU was increased in the absence of SmcR (Fig. 5A) , and SmcR bound to a region (Ϫ128 to Ϫ62) upstream of hlyU in EMSA (Fig. 5D ). In this region we also found a 22-bp sequence (Ϫ107 to Ϫ86) with 68% (15/22) identity to the consensus SmcR-binding sequence proposed by Lee et al. (14) . These findings collectively suggest that SmcR negatively regulates the expression of vvhA by repressing hlyU. It has been shown that HlyU activates rtxA1 expression through competition with H-NS, a repressor of rtxA1, for binding to the promoter region of rtxA1 (20) . We found in this study that the cytolysin/hemolysin activity in the conditioned medium of cells infected by the ⌬hns, ⌬hlyU ⌬hns, or ⌬smcR ⌬hlyU ⌬hns mutant was significantly higher than those infected by their hns ϩ parent strains (Fig. 6B) , suggesting that H-NS also represses the vvhA promoter.
As it has been shown that HlyU increases the rtxA1 promoter activity only in the presence of H-NS (19), we supposed that HlyU regulates the vvhBA promoter in a similar manner. Surprisingly, the cytolysin/hemolysin activity of the ⌬hlyU ⌬hns or ⌬smcR ⌬hlyU ⌬hns mutant was much higher than, instead of comparable to, that of the ⌬hns mutant (Fig. 6B ). This can be explained by the downregulation of the metalloprotease Vvp in the absence of SmcR (27) or HlyU (11) . The cytolysin/hemolysin activity, which declines after late log phase in a wild-type strain, is sustained in the stationary phase in a ⌬vvp mutant (26) , suggesting that cytolysin/hemolysin is inactivated in the presence of Vvp. Therefore, the higher cytolysin/hemolysin activity in the ⌬hlyU ⌬hns or ⌬smcR ⌬hlyU ⌬hns mutant compared to that of the ⌬hns mutant may be a consequence of reduced Vvp activity.
By epistasis analysis we showed that the reduced cytotoxicity of the ⌬luxO mutant was restored when smcR was further deleted (Fig. 1A) , and this double mutant lost cytotoxicity again when its hlyU gene was disrupted (Fig. 4A) . Furthermore, the cytotoxicity of the ⌬smcR ⌬hlyU mutant was regained by deleting the hns gene (Fig. 6A) . Taken together, how LuxO regulates the cytotoxicity may be delineated: LuxO represses smcR to result in the derepression of hlyU, and the up-expressed HlyU then interferes with H-NS to cause the derepression of both vvhA and rtxA1.
Opposite findings on the roles of SmcR in cytotoxicity and virulence in mice have been reported (16) . We previously characterized a ⌬smcR mutant of a clinical isolate, YJ016, and found that both the transcriptional level of vvhA and cytolysin/ hemolysin activity in this mutant were remarkably increased (26) . In addition, the virulence of this mutant in either normal or iron-overloaded C3H/HeN mice challenged by intraperitoneal injection was comparable to that of the wild-type strain. However, an smcR mutant derived from another clinical strain, ATCC 29307, exhibited decreased cytotoxicity to INT407 cells and was less virulent in ICR mice (16) . These differences may result from the different bacterial strains, cell lines, or mouse strains used, and they also suggest that it is necessary to study the roles of SmcR at different sites in the host, such as the gastrointestinal tract and blood, during infection.
